The incidence of non-alcoholic fatty liver disease (NAFLD) is rising rapidly across the globe. NAFLD pathogenesis is largely driven by an imbalance in hepatic energy metabolism, and at present, there is no approved drug for its treatment. The liver plays a crucial role in micronutrient metabolism, and deregulation of this micronutrient metabolism may contribute to the pathogenesis of NAFLD. Vitamins regulate several enzymatic processes in the liver, and derangement in vitamin metabolism is believed to play a critical role in NAFLD progression. The anti-oxidant activities of vitamins C and E have been attributed to mitigate hepatocyte injury, and alterations in the serum levels of vitamin D, vitamin B12 and folate have shown a strong correlation with NAFLD severity. This review aims to highlight the role of these vitamins, which represent promising therapeutic targets for the management of NAFLD.

Objective: Eucalyptus and Curcuma species are well reputed for their traditional medicinal uses in south east Asia, therefore, the present study was designed to determine reducing potential of their essential oils. Method: Essential oils of the selected medicinal species Eucalyptussideroxylon, E. teriticornis, E. citriodora, Curcuma longa and C. aromatic were extracted using hydro distillation method, separated with diethyl ether and dried over anhydrous sodium sulphate. Column chromatography of Curcuma aromatica was carried out and six fractions were collected using gradient solvent system of n-hexane-ethyl acetate. Ferric reducing antioxidant power (FRAP) of oils were evaluated using standard protocol and results were expressed in μM equivalent to FeSO4.7H2O. Results: The essential oil of Eucalyptus sideroxylon was found to possess highest reducing potential among the Eucalyptus species. Curcuma longa essential oil showed most significant reducing potential with 138.4±1.1 FRAP equivalents. Conclusions:It was concluded that the all essential oil and the column fractions of C. aromatica possess significant reducing capacity ranged from 95.8±1.0 to 152.4±1.4 μM in a dose dependent manner.